The switch from brand name to generic cholesterol medications that occurred between 2014 and 2018 has saved Medicare billions of dollars, even as the number of people on cholesterol-lowering drugs has increased, scientists have calculated. Their data suggest that policymakers and clinicians could help cut Medicare costs even further by switching more patients to generic drugs.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200909114837.htm
No comments:
Post a Comment